Multi-component Environmental Package for Food Allergy Prevention

(SHAPE Trial)

TA
MH
Overseen ByMackenzie Haggstrom, BHSc
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: McMaster University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if the Multi-component Environmental Package can prevent food allergies in newborns at higher risk. The package includes guidelines such as delaying a baby's first bath, using fewer cleansers, and avoiding certain cleaning products and food exposures. Researchers will divide families into two groups: one will follow the package, while the other will continue their usual routines. Families with a healthy newborn who is an only child or has close relatives with allergies, asthma, or related conditions might be suitable participants. As an unphased trial, this study offers families the chance to contribute to groundbreaking research that could shape future guidelines for preventing food allergies in newborns.

Will I have to stop taking my current medications?

The trial information does not specify whether participants must stop taking their current medications. It seems focused on newborns and their risk factors for food allergies, so it might not directly affect your current medications.

What prior data suggests that this multi-component environmental package is safe for infants?

Research has shown that the multi-component environmental package (MEP) is generally well-tolerated. Studies have found that introducing mixtures of allergenic foods early in life is safe. For example, starting allergenic foods early did not cause severe side effects. Some research even suggests this might help prevent food allergies.

However, evidence indicates that introducing multiple allergenic foods can lead to higher dropout rates in studies. This may suggest some discomfort or inconvenience, but no serious safety issues have been reported. Overall, the MEP appears safe based on current data, though participants should be aware of potential minor concerns.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores a unique approach to preventing food allergies through environmental adjustments rather than traditional medical treatments like allergy medications or immunotherapy. This multi-component environmental package focuses on lifestyle and hygiene modifications, such as delaying a newborn's first bath and avoiding certain soaps and detergents, which could reduce the risk of food allergies. By minimizing exposure to potential allergens and irritants early in life, this method could offer a natural, non-invasive alternative to current prevention strategies. This approach has the potential to reshape how we think about and manage food allergy prevention from birth.

What evidence suggests that this multi-component environmental package is effective for preventing food allergies?

This trial will compare a multi-component environmental package with a control group to prevent food allergies in infants. Studies have shown that introducing foods early can help prevent food allergies in babies. Research suggests that giving babies allergenic foods, like peanuts or eggs, between 2 to 12 months old can lower their risk of developing allergies. In this trial, the intervention group will follow specific recommendations, such as delaying a baby's first bath, using gentle soaps, and limiting skin contact with allergens. These strategies, combined with early food introduction, offer promising ways to prevent food allergies in infants at higher risk.23567

Who Is on the Research Team?

DC

Derek Chu, MD, PhD, FRCPC

Principal Investigator

McMaster University

Are You a Good Fit for This Trial?

This trial is for healthy, full-term newborns (born at or after 37 weeks) who have a higher risk of food allergies due to family history or being an only child. Parents must give consent and be able to participate in study activities like online surveys and office visits.

Inclusion Criteria

My baby was born healthy and at or after 37 weeks of pregnancy.
Newborn with any of the following risk factors: only child, first-degree relatives with history of food allergy, allergic rhinitis/conjunctivitis, asthma, or atopic dermatitis
Parent(s)/guardian provided informed consent for the child's study participation

Exclusion Criteria

No access to phone, internet, or email
Newborns born to mothers with positive routine prenatal screening for vertically transmitted diseases
Inability to adhere to study procedures due to severe maternal conditions or neonatal skin conditions
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

Up to 8 weeks
1 visit (in-person)

Randomization and Initial Instructions

Participants are randomized to either the multi-component environmental package or regular care and receive initial instructions

Within 24 hours of birth
1 visit (in-person)

Treatment

Participants follow the assigned care regimen, with adherence tracked through weekly diaries and web-based questionnaires

12 months
In-office visits at 4 and 12 months, web-based questionnaires at 4, 6, 9, and 12 months

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessment of food allergy and atopic dermatitis

Up to 18 months
Follow-up assessments as needed

What Are the Treatments Tested in This Trial?

Interventions

  • Multi-component environmental package

Trial Overview

The study compares a multi-component environmental package (MEP) designed to prevent food allergies with standard care. Babies are randomly assigned to either group shortly after birth, with follow-up through diaries, questionnaires, and clinic visits during the first year.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Intervention GroupExperimental Treatment1 Intervention
Group II: Control GroupExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

McMaster University

Lead Sponsor

Trials
936
Recruited
2,630,000+

Citations

Timing of Allergenic Food Introduction and Risk ...

Introducing multiple allergenic foods from 2 to 12 months of age was associated with reduced risk of any food allergy but increased risk of withdrawal from the ...

Estimated risk reduction to packaged food reactions by ...

The population treated with the 250-μg patch demonstrated a significantly increased dose-response distribution after 12 months of treatment, which resulted in a ...

Effectiveness of Home-Based, Multi-Trigger ...

Home-based, multi-trigger, multicomponent interventions with an environmental focus are effective in improving overall quality of life and productivity in ...

Updates in Food Allergy Prevention in Children | Pediatrics

It is now widely accepted that early food introduction has a role in the prevention of food allergy, especially in higher-risk infants.

Facts and Statistics

Two-thirds of the treatment group were able to ingest a significant amount of peanuts compared to only 7% in the placebo group. This biologic therapy was ...

Early Introduction of Multi-Allergen Mixture for Prevention of ...

The results of this study suggest that the early introduction of foods, particularly simultaneous mixtures of many allergenic foods, may be safe and efficacious ...

Proactive Allergen Prevention in the Foodservice Industry

This article discusses how to prevent allergen cross-contamination in a foodservice environment, with expert guidance on methods and best ...